←Back to Expert Scholars
Translational Medicine / 转化医学FGFR Inhibitor Therapy
Robin Katie
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Assistant Professor of Medicine
25
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Robin Katie focuses on cholangiocarcinoma clinical research and FGFR targeted therapy. Her work characterizes mechanisms of resistance to FGFR inhibitors and informs next line strategies. She contributes to multicenter trials in biliary tract cancer. Her research supports rational sequencing of FGFR targeted agents.
Share:
🧪Research Fields 研究领域
cholangiocarcinoma
FGFR inhibitors
resistance mechanisms
clinical trials
gastrointestinal oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Robin Katie 的研究动态
Follow Robin Katie's research updates
留下邮箱，当我们发布与 Robin Katie（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment